SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTBETON (82290),
this company of category PME
shows in 2022 a revenue of 3.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY (SIREN 534799358)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
3 150 762 €
2 972 917 €
2 747 903 €
2 670 693 €
2 556 701 €
2 571 046 €
Net income
160 986 €
160 132 €
136 928 €
185 167 €
168 962 €
258 101 €
151 047 €
131 373 €
143 589 €
EBITDA
N/C
N/C
N/C
288 533 €
268 467 €
269 875 €
245 949 €
239 527 €
255 265 €
Net margin
N/C
N/C
N/C
5.9%
5.7%
9.4%
5.7%
5.1%
5.6%
Revenue and income statement
In 2025, SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY generates positive net income of 161 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 144 k€ -> 161 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
160 986 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 57%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
56.62%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.365%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
216.338
169.787
130.614
82.689
159.045
119.709
94.178
72.404
56.62
Financial autonomy
27.792
32.154
37.386
47.027
33.39
39.397
45.515
48.484
55.365
Repayment capacity
10.424
9.788
7.833
5.671
7.333
6.124
None
None
None
Cash flow / Revenue
6.416%
6.284%
6.727%
7.087%
6.773%
6.91%
None%
None%
None%
Sector positioning
Debt ratio
56.622025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of SELARL PHARMACIE FERTE CH... (56.62) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
55.37%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+6 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE FERTE CH... (55.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 162.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
110.366
110.993
112.369
128.908
130.365
148.944
160.996
140.77
162.939
Interest coverage
13.585
13.211
8.708
5.267
3.053
4.166
None
None
None
Sector positioning
Liquidity ratio
162.942025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average
In 2025, the liquidity ratio of SELARL PHARMACIE FERTE CH... (162.94) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
244 866 €
260 809 €
207 166 €
230 604 €
255 136 €
252 534 €
0 €
0 €
0 €
Inventory turnover (days)
28
30
30
30
31
30
0
0
0
Customer payment term (days)
8
9
5
7
5
6
0
0
0
Supplier payment term (days)
50
57
52
51
46
42
0
0
0
Positioning of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY is estimated at
2 557 281 €
(range 1 735 383€ - 4 012 727€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1735k€2557k€4012k€
2 557 281 €Range: 1 735 383€ - 4 012 727€
NAF 5 année 2025
Valuation method used
Net Income Multiple
160 986 €
×
15.9x
=2 557 282 €
Range: 1 735 383€ - 4 012 727€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY
What is the revenue of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY ?
The revenue of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY in 2022 is 3.2 M€.
Is SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY profitable?
Yes, SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY generated a net profit of 161 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY ?
The headquarters of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY is located in MONTBETON (82290), in the department Tarn-et-Garonne.
Where to find the tax return of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY ?
The tax return of SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY operate?
SELARL PHARMACIE FERTE CHAUMERLIAC SAPHARY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart